VC Firm Targeted Technology Secures $40 Million+ Geared Towards Early-Stage Biotechs
9/5/2014 6:57:38 AM
If there is one area where San Antonio must gain significant ground if it hopes to play with the all-star cities in the bioscience arena, it is venture capital fundraising. In a nutshell, the Alamo City needs more money to retain and recruit additional companies and talent.
At least one San Antonio organization is doing its part to grow the amount of venture capital funding available for early-stage biotech companies. Targeted Technology has closed its second fund, raising more than $40 million.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by